We have located links that may give you full text access.
Journal Article
Meta-Analysis
What meta-analyses reveal about the replicability of psychological research.
Psychological Bulletin 2018 December
Can recent failures to replicate psychological research be explained by typical magnitudes of statistical power, bias or heterogeneity? A large survey of 12,065 estimated effect sizes from 200 meta-analyses and nearly 8,000 papers is used to assess these key dimensions of replicability. First, our survey finds that psychological research is, on average, afflicted with low statistical power. The median of median power across these 200 areas of research is about 36%, and only about 8% of studies have adequate power (using Cohen's 80% convention). Second, the median proportion of the observed variation among reported effect sizes attributed to heterogeneity is 74% (I2). Heterogeneity of this magnitude makes it unlikely that the typical psychological study can be closely replicated when replication is defined as study-level null hypothesis significance testing. Third, the good news is that we find only a small amount of average residual reporting bias, allaying some of the often-expressed concerns about the reach of publication bias and questionable research practices. Nonetheless, the low power and high heterogeneity that our survey finds fully explain recent difficulties to replicate highly regarded psychological studies and reveal challenges for scientific progress in psychology. (PsycINFO Database Record (c) 2018 APA, all rights reserved).
Full text links
Related Resources
Trending Papers
Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.International Journal of Molecular Sciences 2024 April 13
Executive Summary: State-of-the-Art Review: Unintended Consequences: Risk of Opportunistic Infections Associated with Long-term Glucocorticoid Therapies in Adults.Clinical Infectious Diseases 2024 April 11
Clinical practice guidelines on the management of status epilepticus in adults: A systematic review.Epilepsia 2024 April 13
Finerenone: From the Mechanism of Action to Clinical Use in Kidney Disease.Pharmaceuticals 2024 March 27
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app